September 25, 2025
13,348
148
9
1.18%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
0:25Now Playing
1:31A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary trial.
The experimental treatment, called AMT-130, reduced disease progression by 75% over three years in patients who received a high dose, compared to those on standard care, according to researchers.
While these early results are promising, they are preliminary and the treatment could still years away from potential FDA approval, with the earliest application expected in 2026.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.